Fig. 1From: Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancersThe design of this study. SCLC, small cell lung carcinoma; TMB, tumor mutation burden; MSI, microsatellite instability; HRD, homologous recombination deficiencyBack to article page